Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis

Borderline personality disorder (BPD) is a debilitating psychiatric disorder that affects 0.4-3.9% of the population in Western countries. Currently, no medications have been approved by regulatory agencies for the treatment of BPD. Nevertheless, up to 96% of patients with BPD receive at least one psychotropic medication.The objective of this systematic review was to assess the general efficacy and the comparative effectiveness of different...